skip navigation
National Criminal Justice Reference Service
Login | Subscribe/Register | Manage Account | Shopping Cartshopping cart icon | Help | Contact Us | Home     
National Criminal Justice Reference Service
  Advanced Search
Search Help
     
| | | | |
place holder
Administered by the Office of Justice Programs U.S. Department of Justice Office of Justice Programs Seal National Criminal Justice Reference Service National Criminal Justice Reference Service Office of Justice Programs Seal National Criminal Justice Reference Service
Topics
A-Z Topics
Corrections
Courts
Crime
Crime Prevention
Drugs
Justice System
Juvenile Justice
Law Enforcement
Victims
Left Nav Bottom Line

Home / Spotlight / Club Drugs

Club Drugs
Summary
·Facts & Figures
·Legislation
·Publications
·Programs
·Training & Technical Assistance
·Grants & Funding
·Related Resources

Club Drugs

“NIDA (National Institute on Drug Abuse)-supported research has shown that use of club drugs can cause serious health problems and, in some cases, even death. Used in combination with alcohol, these drugs can be even more dangerous. No club drug is benign” (ClubDrugs.gov, National Institute on Drug Abuse). 

Summary

"Club drug" is a vague term that refers to a wide variety of drugs including MDMA (Ecstasy), GHB, Rohypnol, ketamine, methamphetamine, and LSD. Uncertainties about the drug sources, pharmacological agents, chemicals used to manufacture them, and possible contaminants make it difficult to determine toxicity, consequences, and symptoms (Community Drug Alert Bulletin: Club Drugs, National Institute on Drug Abuse, 2004).

To some, club drugs seem harmless. In reality, these substances can cause serious physical and psychological problems—even death. Often, the raves where these drugs are used are promoted as alcohol-free events, which gives parents a false sense of security that their children will be safe attending such parties. These parents are not aware that raves may actually be havens for the illicit sale and abuse of club drugs (Information Bulletin: Raves, National Drug Intelligence Center, 2001).

Attendance at raves can range from 30 people in a small club to thousands in a stadium or open field. Because MDMA can cause users to involuntarily grind their teeth, ravers often chew on baby pacifiers or lollipops to offset this effect. Additionally, ravers may use glowsticks and flashing lights to heighten the hallucinogenic properties of MDMA and the visual distortions brought on by its use (Information Bulletin: Raves, National Drug Intelligence Center, 2001).

There are numerous dangers associated with the use of club drugs. For example:

  • MDMA can cause a user's blood pressure and heart rate to increase to dangerous levels, and can lead to heart or kidney failure. It can cause severe hyperthermia from the combination of the drug's stimulant effect with the often hot, crowded atmosphere of a rave (MDMA (Ecstasy) Abuse Research Report, National Institute on Drug Abuse, 2005).
  • Studies have shown that some heavy MDMA users experience long lasting confusion, depression, and selective impairment of working memory and attention processes (MDMA (Ecstasy) Abuse Research Report, National Institute on Drug Abuse, 2005).
  • Rohypnol and GHB are predominantly central nervous system depressants. Because they are often colorless, tasteless, and odorless, they can be added to beverages and ingested unknowingly (InfoFacts: Rohypnol and GHB, National Institute on Drug Abuse, 2006).
  • Low-dose intoxication from ketamine results in impaired attention, learning ability, and memory. At higher doses, ketamine can cause delirium, amnesia, impaired motor function, high blood pressure, depression, and potentially fatal respiratory problems (Community Drug Alert Bulletin: Club Drugs, National Institute on Drug Abuse, 2004).
  • Methamphetamine is a powerfully addictive stimulant associated with serious health conditions, including memory loss, aggression, and potential heart and brain damage. Users can also display a number of psychotic features, including paranoia, auditory hallucinations, mood disturbances, and delusions (Methamphetamine Abuse and Addiction Research Report, National Institute on Drug Abuse, 2006).

Because of the dangers associated with the use of club drugs, communities and law enforcement agencies are developing anti-rave initiatives to try to curb the use of club drugs. For example, they are passing new ordinances that establish juvenile curfews and licensing requirements for large public gatherings and are enforcing existing fire codes and health, safety, and liquor laws (Information Bulletin: Raves, National Drug Intelligence Center, 2001).

This topical resource on Club Drugs contains the following information:

Facts and Figures – Includes the latest information and statistics.
Legislation – A sample of links to online Federal and State legislation and testimony.
Publications – A sample of available resources.
Programs – Examples of State and local programs and initiatives available online.
Training and Technical Assistance – A sample of training and technical assistance opportunities available through nationally recognized agencies and associations.
Grants and Funding – Links to Federal funding opportunities.
Related Resources – Examples of nationally recognized agencies and organizations that provide services or information.

Links from the NCJRS Web site to non-Federal sites do not constitute an endorsement by NCJRS or its sponsors. NCJRS is not responsible for the content or privacy policy of any off-site pages that are referenced, nor does NCJRS guarantee the accuracy, completeness, timeliness, or correct sequencing of information. NCJRS is also not responsible for the use of, or results obtained from the use of, the information. It is the responsibility of the user to evaluate the content and usefulness of information obtained from non-Federal sites.

Last updated on: 12/14/2007



Contact Us | Feedback | Site Map
Freedom of Information Act | Privacy Statement | Legal Policies and Disclaimers | USA.gov

U.S. Department of Justice | Office of Justice Programs | Office of National Drug Control Policy

place holder